Moderna wants you to “Spikevax that body.” In an ad that contrasts sharply with Pfizer’s celeb-loaded TV spot, the mRNA specialist is pitching its COVID-19 vaccine as another part of a healthy ...
June 3 (Reuters) - Moderna (MRNA.O), opens new tab and partner Merck & Co (MRK.N), opens new tab said on Monday their cancer vaccine in combination with blockbuster cancer therapy Keytruda improved ...
Back in January, Moderna set a planned mpox vaccine on the back burner as the immediate outbreak waned, but now the shot has slid into the priority lane, with entry to the clinic likely a “month or so ...
Every time Andrew publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...
After tweaking the formula behind an mRNA flu vaccine, Moderna has finally met all the goals needed for a successful shot in a phase 3 trial. Now, CEO Stéphane Bancel is eyeing a launch as early as ...
Moderna stock has faced heavy pressure from negative headlines, regulatory setbacks, and political uncertainty, but recent FDA approvals have stabilized sentiment. The company now boasts three ...
Boston-based Moderna has been the S&P 500’s most shorted stock since the end of September, according to S3 Partners. Short sellers had about $622mn of unrealised profits in the company in 2025, S3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback